Published in Retina on April 01, 2013
Initial Versus Delayed PDT Combination With Conbercept in PCV | NCT02821520
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response. Br J Ophthalmol (2013) 1.61
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol (2014) 1.41
Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration. Drug Des Devel Ther (2013) 0.99
Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2016) 0.96
Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies. PLoS One (2014) 0.93
Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium. Invest Ophthalmol Vis Sci (2014) 0.92
Prospective evaluation of subretinal vessel location in polypoidal choroidal vasculopathy (PCV) and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2014) 0.91
Defining response to anti-VEGF therapies in neovascular AMD. Eye (Lond) (2015) 0.88
Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development. Clin Ophthalmol (2015) 0.83
A prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy. PLoS One (2014) 0.83
Photodynamic therapy: current role in the treatment of chorioretinal conditions. Eye (Lond) (2016) 0.80
Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.80
EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study. Graefes Arch Clin Exp Ophthalmol (2016) 0.80
Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV). PLoS One (2015) 0.79
Systematic review and meta-analysis of the association between complement factor H I62V polymorphism and risk of polypoidal choroidal vasculopathy in Asian populations. PLoS One (2014) 0.79
Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study. Graefes Arch Clin Exp Ophthalmol (2016) 0.78
Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern. Clin Ophthalmol (2014) 0.78
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy. BMC Ophthalmol (2015) 0.78
Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy. BMC Ophthalmol (2015) 0.77
Baseline polyp size as a potential predictive factor for recurrence of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.77
One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2016) 0.77
[Forms of age-related macular degeneration]. Ophthalmologe (2015) 0.77
Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review. Int J Ophthalmol (2017) 0.75
Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients. Korean J Ophthalmol (2016) 0.75
Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results. BMC Ophthalmol (2016) 0.75
Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series. Int J Retina Vitreous (2016) 0.75
Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2015) 0.75
Acute angle closure glaucoma secondary to polypoidal choroidal vasculopathy - a devastating complication. GMS Ophthalmol Cases (2017) 0.75
Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population. Indian J Ophthalmol (2016) 0.75
Automatic Segmentation of Polypoidal Choroidal Vasculopathy from Indocyanine Green Angiography Using Spatial and Temporal Patterns. Transl Vis Sci Technol (2015) 0.75
Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy. Turk J Ophthalmol (2016) 0.75
The Features of Inflammation Factors Concentrations in Aqueous Humor of Polypoidal Choroidal Vasculopathy. PLoS One (2016) 0.75
Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab. Case Rep Ophthalmol (2017) 0.75
Combined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathy. Oman J Ophthalmol (2016) 0.75
Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy. Turk J Ophthalmol (2016) 0.75
Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps. Korean J Ophthalmol (2015) 0.75
Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters. Korean J Ophthalmol (2016) 0.75
Association of rs6982567 near GDF6 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Han Chinese cohort. BMC Ophthalmol (2014) 0.75
Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy. Indian J Ophthalmol (2013) 0.75
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration. BMC Ophthalmol (2016) 0.75
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy. BMC Ophthalmol (2016) 0.75
Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom. Int J Retina Vitreous (2017) 0.75
Treatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy. Sci Rep (2016) 0.75
C2 rs547154 polymorphism and polypoidal choroidal vasculopathy susceptibility: a meta-analysis. Sci Rep (2015) 0.75
High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population. Eye (Lond) (2015) 0.75
Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor. Korean J Ophthalmol (2015) 0.75
Evidence of a novel gene HERPUD1 in polypoidal choroidal vasculopathy. Int J Clin Exp Pathol (2015) 0.75
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration. J Ophthalmol (2015) 0.75
Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Radiating hemorrhage in exudative age-related macular degeneration. Jpn J Ophthalmol (2016) 0.75
Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience. Indian J Ophthalmol (2017) 0.75
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Corticosteroids and central serous chorioretinopathy. Ophthalmology (2002) 3.37
Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone-iodine. Am J Ophthalmol (2010) 3.14
Choroidal thickness in both eyes of patients with unilateral idiopathic macular hole. Ophthalmology (2012) 2.78
Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula. Am J Ophthalmol (2010) 2.64
Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology (2010) 2.61
Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci (2012) 2.58
Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol (2007) 2.53
Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol (2010) 2.37
Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study. Clin Infect Dis (2013) 2.25
Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina (2011) 2.22
Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology (2008) 2.17
Extraocular Technique of Intrascleral Intraocular Lens Fixation Using a Pair of the Shaft-Bended 27-Gauge Needles. Retina (2017) 2.09
Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema. Retina (2015) 2.08
The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology (2010) 1.97
Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci (2011) 1.92
Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy. Indian J Ophthalmol (2012) 1.89
Resolution of retinoschisis after vitreous surgery in X-linked retinoschisis. Ophthalmology (2007) 1.82
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol (2008) 1.80
Endophthalmitis caused by Acinetobacter calcoaceticus. A profile. Indian J Ophthalmol (2003) 1.77
Choroidal thickness in healthy Chinese subjects. Invest Ophthalmol Vis Sci (2011) 1.74
Serous detachment of the retina. Retina (2003) 1.73
Primary malignant melanoma of the female urethra. Korean J Urol (2012) 1.72
Correlation of optical coherence tomography with angiography in retinal pigment epithelial detachment associated with age-related macular degeneration. Retina (2004) 1.70
Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy. Urology (2010) 1.64
Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina (2011) 1.59
Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study. Korean J Urol (2010) 1.59
Characteristics of peripapillary choroidal cavitation detected by optical coherence tomography. Ophthalmology (2012) 1.57
The effects of renal transplantation on diabetic retinopathy: clinical course and visual outcomes. Indian J Ophthalmol (2013) 1.56
Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol (2011) 1.54
Long-term observation of fundus infrared fluorescence after indocyanine green-assisted vitrectomy. Retina (2007) 1.54
HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle (2007) 1.53
Diminished ciliary muscle movement on accommodation in myopia. Exp Eye Res (2012) 1.50
Hemi-central retinal artery occlusion in young adults. Indian J Ophthalmol (2010) 1.49
AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J Clin Invest (2008) 1.49
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer (2008) 1.48
Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. J Atheroscler Thromb (2010) 1.48
Knowledge of diabetes and diabetic retinopathy among rural populations in India, and the influence of knowledge of diabetic retinopathy on attitude and practice. Rural Remote Health (2008) 1.48
Identification of a microdeletion at Xp22.13 in a Taiwanese family presenting with Nance-Horan syndrome. J Hum Genet (2010) 1.46
Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest (2006) 1.46
Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes (2005) 1.45
Influence of dietary-fibre intake on diabetes and diabetic retinopathy: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (report 26). Clin Experiment Ophthalmol (2011) 1.43
Frequency, source, and prevention of cotton fibers in the anterior chamber during cataract surgery. J Cataract Refract Surg (2008) 1.43
Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy. Graefes Arch Clin Exp Ophthalmol (2010) 1.43
Dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy. Retina (2010) 1.43
Trace elements iron, copper and zinc in vitreous of patients with various vitreoretinal diseases. Indian J Ophthalmol (2004) 1.43
A genome-wide association analysis identified a novel susceptible locus for pathological myopia at 11q24.1. PLoS Genet (2009) 1.43
Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2011) 1.42
The 5-year functional outcomes after radical prostatectomy: a real-life experience in Korea. Asian J Androl (2010) 1.42
Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology. Ophthalmic Epidemiol (2005) 1.40
TRPV3 and TRPV4 ion channels are not major contributors to mouse heat sensation. Mol Pain (2011) 1.38
Morphologic analysis of stage 3 and stage 4 macular holes: implications for treatment. Am J Ophthalmol (2005) 1.38
Transpupillary thermotherapy for choroidal neovascular membrane in age related macular degeneration. Indian J Ophthalmol (2004) 1.38
Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol (2011) 1.36
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood (2011) 1.36
Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci (2008) 1.34
Submacular hemorrhage: a study amongst Indian eyes. Indian J Ophthalmol (2012) 1.29
Retinoblastoma: one world, one vision. Pediatrics (2008) 1.29
AIP1 is critical in transducing IRE1-mediated endoplasmic reticulum stress response. J Biol Chem (2008) 1.27
Coats' disease: an Indian perspective. Indian J Ophthalmol (2010) 1.26
ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Am J Ophthalmol (2009) 1.23
AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation. Circ Res (2008) 1.23
Persistent foveal retinal detachment after successful rhegmatogenous retinal detachment surgery. Am J Ophthalmol (2002) 1.21
Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Am J Ophthalmol (2012) 1.21
Analysis of the complete genome sequence of epidemic keratoconjunctivitis-related human adenovirus type 8, 19, 37 and a novel serotype. J Gen Virol (2009) 1.20
Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy. Retina (2008) 1.19
CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Invest Ophthalmol Vis Sci (2010) 1.18
Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention. Ophthalmology (2008) 1.18
Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population. Clin Experiment Ophthalmol (2008) 1.18
Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev (2010) 1.17
The clinical spectrum and treatment outcome of retinoblastoma in Indian children. J Pediatr Ophthalmol Strabismus (2005) 1.17
Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol (2009) 1.16
Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr (2010) 1.16
Surgical management of late capsular block syndrome. J Cataract Refract Surg (2010) 1.16
Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 retinopathy of prematurity. Indian J Ophthalmol (2009) 1.16
Eales disease--an update. Surv Ophthalmol (2002) 1.15
Macular retinoschisis associated with normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol (2011) 1.15
The cost-utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology (2012) 1.14
Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2011) 1.14
Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
Double staining with brilliant blue G and double peeling for epiretinal membranes. Ophthalmology (2009) 1.12
Optical coherence tomography characteristics in eyes with optic pit maculopathy. Retina (2013) 1.11
Connective tissue growth factor as a mediator of intraocular fibrosis. Invest Ophthalmol Vis Sci (2008) 1.11
Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol (2009) 1.11
Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity. Pediatr Res (2003) 1.11
Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs. Invest Ophthalmol Vis Sci (2008) 1.11
Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci (2006) 1.09
Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo. Clin Cancer Res (2007) 1.09
Patient satisfaction with tele-ophthalmology versus ophthalmologist-based screening in diabetic retinopathy. J Telemed Telecare (2006) 1.09
Correlation between ocular motility and evaluation of computed tomography in orbital blowout fracture. Am J Ophthalmol (2006) 1.09
Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries. Br J Ophthalmol (2007) 1.08
Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan. Br J Ophthalmol (2010) 1.07
[Clinical effects of photodynamic therapy with Verteporfin for age-related macular degeneration 1: three-month results]. Nippon Ganka Gakkai Zasshi (2006) 1.07